摘要
目的分析急性心肌梗死患者入院时糖化血红蛋白(HbA1c)和血糖水平与接受经皮冠状动脉介入治疗(PCI)后预后水平的关系。方法回顾性分析120例接受PCI治疗的急性心肌梗死患者的临床资料,将患者依据是否出现HbA1c增高分为增高组(A组)与对照组(B组)。对比2组患者的一般资料、临床疗效以及心血管不良事件发生率。结果 2组患者除糖尿病发生率外一般资料差异无统计学意义(P>0.05)。增高组患者治疗后Killip分级显著高于对照组(P<0.05),增高组患者左心房内径、左室射血分数、左室舒张期内径与对照组差异存在统计学意义(P<0.05或P<0.01)。增高组患者的再发心肌梗死和频发室性期前收缩发生率显著高于对照组(P<0.05)。结论入院时HbA1c升高对于急性心肌梗死患者的预后以及心血管不良事件发生率具有显著影响。
Objective To investigate the relationship between plasma HbA1c and prognosis in acute myocar‐dial infarction patients undergoing percutaneous coronary intervention .Methods A total of 120 acute myocardial infarction patients undergoing percutaneous coronary intervention were divided into two groups ,patients with higher plasma HbA1 c level as group A and patients with normal plasma HbA1 c level as group B .The general da‐ta ,prognosis and incidence of cardiovascular adverse events were compared between two groups .Results There was no significant difference of general data ,except diabetes rate （P〉0.05） .The Killip in group A was signifi‐cantly higher than that in group B after treatment （P〈0 .05） .There was a significant difference of LA ,LVDd and LVEF between group A and group B （P〈0 .05 ,P〈0 .01） .The recurrent and premature ventricular contrac‐tion rates in group A were significantly less than those in group B .Conclusion Plasma HbA1 c level has a signifi‐cant influence on the prognosis and cardiovascular adverse events of PCI treatment patients .
出处
《山西医药杂志》
CAS
2015年第18期2098-2100,共3页
Shanxi Medical Journal
基金
河北省沧州市科技局项目(131302108)
关键词
血红蛋白A
糖基化
心肌梗塞
预后
Hemoglobin A,glycosylation
Myocardial infarction
Prognosis
